FeesSafety
Pluang+

Crypto portfolio drops 69% from $28.5M to $8.9M, but upside potential remains, says Bonk Guy

Market News
27 Oct 2026, 00:57 WIB
Tokenpost
View Source
Neutral
Crypto portfolio drops 69% from $28.5M to $8.9M, but upside potential remains, says Bonk Guy

Bonk Guy's crypto portfolio has fallen 69% from a peak of $28.5 million about six weeks ago to roughly $8.9 million. Despite the steep decline, he believes the risk-reward balance favors upside and that most of the portfolio's drop has already occurred. His main holdings include PONS, USELESS, and MARSCOIN, with recent increases in MASK and SI. He also sees potential in PANGEA and VRAX, though they carry higher risk. Bonk Guy emphasizes cross-chain diversification as a strategy to reach new portfolio highs and has maintained the top spot on FOMO's leaderboard for over two months.

Bonk Guy's crypto portfolio fell 69% from a $28.5 million peak. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 27, 2026 05:02 WIB: out of 50 priced major cryptocurrencies, 24 rose and 24 fell today. Notable movers include ZIL (Zilliqa) at Rp35 with a 1-day change of +3.75% and Pluang order activity of 58% Sell / 42% Buy, VET (VeChain) at Rp118 with a 1-day change of -3.58% and 91% Sell / 9% Buy order activity, and GRT (The Graph) at Rp397 with a 1-day change of -2.71% and 13% Sell / 87% Buy order activity.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
1 hour ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App